The content on this site is intended for healthcare professionals only
Molecular chaperones: cancer dependence and druggability
Prof Paul Workman - The Institute of Cancer Research, Sutton, UK
19 Jan 2011
Chemoradiotherapy for bladder cancer
Prof Nick James - Queen Elizabeth Hospital and University of Birmingham, UK
14 Jan 2011
Raising public awareness of HPV induced malignancy
Prof Clare Wilkinson - Cardiff University, UK
11 Jan 2011
Advances in the treatment of renal cancer
Prof Tim Eisen - University of Cambridge, UK
11 Jan 2011
The role of radiotherapy in the treatment of prostate cancer
Prof Malcolm Mason - Cardiff University, UK
11 Jan 2011
Patients as partners in oncopolicy
Tom Hudson - President of European Cancer Patient Coalition
21 Dec 2010
World Health Organisation cancer prevention and control
Dr Andreas Ullrich - World Health Organisation Medical Officer
21 Dec 2010
The European Academy of Cancer Sciences
Prof Alexander Eggermont and Prof Anton Berns
21 Dec 2010
Prostate screening and the Forum Against Cancer Europe
Prof Louis Denis - Oncology Centre, Antwerp, Belgium
17 Nov 2010
How to select targeted therapy in renal cancer
Prof Bernard Escudier - Institut Gustave Roussy, Paris, France
10 Nov 2010
The development of PARP inhibitors a new drug to treat prostate cancer
Dr Johann de Bono - The Institute of Cancer Research & Royal Marsden Hospital, S...
10 Nov 2010
Cyberknife robotic radiosurgery
Dr Joost Nuyttens - Daniel den Hoed Cancer Centre, Rotterdam, Netherlands
1 Nov 2010
